From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

Takeda and Seattle Genetics are closing in on a new front-line use for their Adcetris in classical Hodgkin lymphoma after a successful late-stage trial. The positive results from the phase 3 ...

NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.

A woman who was diagnosed with stage 2 Hodgkin lymphoma has shared the symptoms that led to diagnosis, and discovering she had blood cancer. According to the NHS, Hodgkin Lymphoma is a "relatively ...

🔬 Breakthrough for late-stage Hodgkin lymphoma: NICE has approved brentuximab vedotin combination therapy as the first treatment specifically for previously untreated stage 3 or 4 classical Hodgkin ...

Patients on Adcetris and chemo had better progression-free and overall survival after six years of follow-up compared to those on chemo only.

Dave Coulier's cancer is in remission! A rep for the 65-year-old 'Full House' actor confirmed that he was cancer-free after a ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

🔬 Breakthrough for late-stage Hodgkin lymphoma: NICE has approved brentuximab vedotin combination therapy as the first treatment specifically for previously untreated stage 3 or 4 classical ...